A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

NCT07363720 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Narcolepsy Type 1 (NT1)
Narcolepsy With Cataplexy

Interventions

DRUG: TAK-861
DRUG: Placebo

Sponsor

Takeda